Hosted by Recruitomics Consulting · 🇺🇸 US · EN · 57 episodes
Established thought leaders with verified media credentials.
From the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies. We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they’ve learned along the way.
Recruitomics Consulting hosts Building Biotechs, a science show with 57 episodes published.
Federico Paoletti, co-founder of Exogene, founded his biotech company immediately after finishing his PhD, which led to a steep learning curve and many valuable lessons he now shares with other founders. He and his co-fo
For our first episode of season three, I sat down with Gabi Hanna, MD, CEO and co-founder of Lamassu Biotech, where he leads the development of innovative therapies for cancer and inflammatory diseases. A physician-scien
This week I had a great conversation with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners. We dive into Russ's unique journey from aspiring exterminator (yes, you read that right!) to leading life science en
This week I chatted with Renee Williams, Founder and Managing Partner at Williams Biotech Consulting. Renee is a seasoned fractional Chief Business Officer (CBO) for small and growing biotechnology companies. Renee share
This week, I spoke with Natalie Nairn, co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition fr
In this episode, I had an engaging conversation with Stacie Frye, co-founder and Chief Commercial Officer of StimulusBio, a life sciences commercialization and venture studio for biotech startups. We discussed how Stimul
This week, I had an insightful conversation with David Sans, PhD, FAARM, MBA, who heads healthcare investment banking at EF Hutton. We discussed the intricacies of different Public Offering strategies, including micro IP
This week I had a great conversation with Iva Toudjarska, founder and CEO of Zeal Therapeutics. From earning a PhD in molecular biology to a solid scientific career at Alnylam, to working in venture capital, to selling a
This week I had a fun conversation with Jason Cordeiro, Chief Operating and Innovation Officer at MassBio. We dissect MassBio's newly announced five-year strategic plan that includes a multi-pronged set of initiatives ai
In this episode, we revisit a fun conversation with Mike LaRhette, Chief Business Officer at LabCentral. Mike outlines the essentials for startups, including funding, lab space, mentorship, and resources. He shares his j
This week I spoke with Bogdan Knezevic, founder of Kaleidoscope Bio, about optimizing biotech workflows and achieving milestones efficiently. Bogdan shared insights into how his platform helps companies manage research a
This week I spoke with Jon Hu, CEO and co-founder of Pepper Bio, about his journey from pharma consulting and venture capital to founding a tech-enabled biotech company. Pepper Bio created an AI and machine learning plat
This week we chatted with Cheri Ackerman, PhD, Cofounder & CEO of Concerto Biosciences. During her postdoctoral work at MIT, she developed the groundbreaking kChip technology that led to the formation of Concerto Bioscie
This week I sat down with Krysta Pellegrino, Chief Client Officer at Health+Commerce, a public relations and marketing agency specifically focused on healthcare. Krysta shared her unique perspective on how biotech compan
In this episode, I had the privilege to interview Bonnie Bertolaet, Ph.D, Executive Director of Science Club for Girls, and Ashley Cooper, MS, MPhil, Curriculum Writer and Evaluation Manager at Science Club for Girls and
In this episode, we had the pleasure of welcoming back Lynn Walder, our first repeat guest, to dive into the pitfalls and best practices of defining culture and core values for growing companies. There has been a shift i
Today, I had the opportunity to speak with Amogha Tadimety, PhD, CEO, and Alison Burklund, PhD, President & CTO, co-founders of Nanopath, an innovative company specializing in women’s health diagnostics. Both hailing fro
In this episode, I sat down with Ben Hemani from Bison Ventures, a venture capital firm that invests in early-stage frontier technology companies. We explore his background in environmental engineering and his transition
This week I sat down with Krisha Panchalingham, Director of Lab and Scientific Operations at Portal Innovations. Krisha shares how she and her team support early-stage biotech companies through the operational intricacie
This week, Carina Clingman, PhD, Founder and Principal of Recruitomics Consulting, outlines an actionable 3-Step framework to simplify the recruitment process and hire top-quality talent. The discussion covers common cha
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
To pitch Building Biotechs, visit https://podcasts.bcast.fm/building-biotechs-a-podcast-by-recruitomics-consulting for contact information, then craft a tight one-paragraph hook that ties your expertise to a gap in their recent science coverage.
Building Biotechs is hosted by Recruitomics Consulting. The show is categorised under science (life) and has published 57 episodes.
Building Biotechs has published 57 episodes.
Building Biotechs regularly covers science, life, business. It sits in the science category, with a life focus.
Building Biotechs is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Building Biotechs hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Building Biotechs average 38 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Building Biotechs's guest bar at 81/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched yesterday.
